NCT00793520View on ClinicalTrials.gov

Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging (fMRI) Activation Patterns in Patients With Fibromyalgia

PHASE3TerminatedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

April 30, 2009

Conditions
Fibromyalgia
Interventions
DRUG

Milnacipran

Twice daily oral administration of Milnacipran for 5 weeks.

DRUG

Placebo

Twice daily oral administration of placebo for 5 weeks.

DRUG

Placebo

Twice daily oral administration of placebo for 5 weeks.

DRUG

Milnacipran

Twice daily oral administration of Milnacipran for 5 weeks.

Trial Locations (1)

48106

Forest Investigative Site, Ann Arbor

Sponsors
All Listed Sponsors
lead

Forest Laboratories

INDUSTRY